Sona Nanotech (CSE:SONA, OTCQB:SNANF) advances nanotechnology medicine through its proprietary gold nanorods that promise to change the face of cancer therapy. Sona Nanotech’s platform technology leverages uniquely biocompatible gold nanorods (GNRs). Biocompatibility is key to the application of nanotechnology in medicine. For the past several years, Sona has been working hard to develop and operationalize...
Nanotechnology’s increasing applications in the medical field are creating an opportunity for investors to participate in this emerging market, according to David Regan, CEO of Sona Nanotech (CSE:SONA,OTCQB:SNANF), a life science company based in Halifax, Nova Scotia. “This innovation is where growth happens,” said Regan. “There’s been a ton of research that has gone into...
Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the “Research Group”). This study aims to evaluate the efficacy of Sona’s Targeted Hyperthermia Therapy (“THT”) technology in not only attenuating the development of colorectal, breast, and...